Michiho Nishioka

Clinicopathological significance of epigenetic inactivation of RASSF1A at 3p21.3 in stage I lung adenocarcinoma.

Yoshio Tomizawa, Takashi Kohno, Haruhiko Kondo et al. · PubMed · 2002 · 112 citations

<i>MYO18B</i> , a candidate tumor suppressor gene at chromosome 22q12.1, deleted, mutated, and methylated in human lung cancer

Michiho Nishioka, Takashi Kohno, Masachika Tani et al. · Proceedings of the National Academy of Sciences · 2002 · 97 citations · Full text

Genetics, Pathology, Cancer Biology +22

Reduced expression of <i>MYO18B</i>, a candidate tumor‐suppressor gene on chromosome arm 22q, in ovarian cancer

Nozomu Yanaihara, Michiho Nishioka, Takashi Kohno et al. · International Journal of Cancer · 2004 · 58 citations · Full text

Genetic and epigenetic alterations of the candidate tumor‐suppressor gene <i>MYO18B</i>, on chromosome arm 22q, in colorectal cancer

Tetsuhiro Nakano, Masachika Tani, Michiho Nishioka et al. · Genes Chromosomes and Cancer · 2005 · 44 citations

Identification of a 428-kb homozygously deleted region disrupting the SEZ6L gene at 22q12.1 in a lung cancer cell line

Michiho Nishioka, Takashi Kohno, Mina Takahashi et al. · Oncogene · 2000 · 43 citations

Medicine, Cancer Genomics, Sez6l Gene +7